Monday’s 4 Biggest Biopharma Movers
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick off the week.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 180
Can Theranos Make It Through 2017?
Theranos's woes are a nearly perfect storm of loss of faith in its products, loss of faith in management, soured partnerships, angry investors and lawsuits.
Friday’s 6 Biopharma Movers That Can’t Be Ignored
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
6 Major FDA Decisions and Biopharma Catalysts Coming in January and February
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much as a Fast Track designation from the FDA.
These 5 Biotech Stocks Could Be Big Takeover Targets in 2017
A new Jefferies research report makes the case that five top biotech companies may be right in the cross-hairs of the biotech giants or perhaps large pharmaceutical companies.
Why These 5 Biopharma Stocks Are Making Massive Gains on Thursday
As the markets are continuing to heat up, a few biopharma stocks made massive gains on Thursday. There is a very positive sentiment in the health care sector in anticipation of the new Trump…
2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
Wednesday’s Top 5 Biopharma Movers
A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care sector…
Braeburn Pharmaceuticals Gears Up for IPO
Braeburn Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Tuesday’s Biggest Biotech and Pharma Moves
To kick off the New Year, Clovis Oncology a few other biotech companies made massive runs on this first day of trading in 2017.
Jounce Therapeutics Files for IPO
Jounce Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Is This the Implosion of Inotek?
Inotek Pharmaceuticals saw its shares get more than halved early on Tuesday after the company provided an update on its late-stage glaucoma trial.
3 Sleeper Biotechs That Could Bounce Back Strong in 2017
2016 was hard for biotech stocks, some more than others. These three present a buy low opportunity.
Will 2017 Be a Make or Break Year for FibroGen?
FibroGen could be a very important stock in its sector in 2017, with its data from multiple studies coming out early in the year.
7 Key FDA Decisions and Catalysts Expected in January and February
24/7 Wall St. has collected several catalysts for biotech and pharmaceutical companies that are coming up in the first two months of 2017.